Showing results (111-120 of 311) with videos related to
Sort By:
Pageof 32
The Journal of Rheumatology|December 29, 2000
Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature reviewI N Bruce, C A Clark-Soloninka, K A Spitzer, et al.Arthritis and Rheumatism|May 1, 1976
Mixed leukocyte reaction in rheumatoid arthritisE C Keystone, D D Gladman, M B Urowitz, et al.The Journal of Rheumatology|February 1, 1994
Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activityW Pruzanski, N J Goulding, R J Flower, et al.Canadian Family Physician Medecin De Famille Canadien|May 15, 2010
Laboratory tests for diagnosing connective tissue diseasesM B UrowitzRheumatic Diseases Clinics of North America|February 1, 1993
Is "aggressive" therapy necessary for systemic lupus erythematosus?M B UrowitzThe Journal of Rheumatology|October 19, 2000
Evaluation of predictive factors for neurocognitive dysfunction in patients with inactive systemic lupus erythematosusD D Gladman, M B Urowitz, D Slonim, et al.The Journal of Rheumatology|August 1, 1994
Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validationD D Gladman, C H Goldsmith, M B Urowitz, et al.The Journal of Rheumatology|April 1, 1992
Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosusD D Gladman, C H Goldsmith, M B Urowitz, et al.Annals of the Rheumatic Diseases|February 15, 2005
Consensus exercise on domains in psoriatic arthritisD D GladmanCurrent Opinion in Rheumatology|October 1, 1992
Prognosis of systemic lupus erythematosus and factors that affect itD D GladmanPageof 32